Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 19, 2012

Drug Name Review Type Class Manufacturer
Stribild New Drug Initial Review HIV Gilead
Bydureon New Drug Initial Review Incretin Mimetics � GLP-1 Analog Amylin
Qnasl New Drug Appeal Intranasal Steroid Teva
Pradaxa PDL Appeal Direct Thrombin Inhibitor Boehringer-Ingelheim